Trademark applications and grants for Genentech Inc. Genentech Inc has 724 trademark applications. The latest application filed is for "ALPHSYNTAG"
Patent Application | Date |
---|---|
CELL LINE DEVELOPMENT IMAGE CHARACTERIZATION WITH CONVOLUTIONAL NEURAL NETWORKS 20220309666 - 17/841610 LI; Zheng ;   et al. | 2022-09-29 |
METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES 20220306766 - 17/711170 KIM; Jeong ;   et al. | 2022-09-29 |
METHOD TO IMPROVE VIRUS FILTRATION CAPACITY 20220306726 - 17/544796 Mehta; Amit | 2022-09-29 |
CHEMICAL COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY 20220306649 - 17/686183 STAFFORD; Jeffrey A. ;   et al. | 2022-09-29 |
TDO2 Inhibitors 20220306635 - 17/068574 Lin; Xingyu ;   et al. | 2022-09-29 |
NCAGE Code | 1HZ12 | GENENTECH, INC. |
CAGE Code | 1HZ12 | GENENTECH, INC. |
S.A.M. Registration | 1HZ12 [80129000] | GENENTECH, INC. |
SEC | 0000318771 | GENENTECH INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.